I-MAB (IMAB)
1.75
-0.01
(-0.57%)
USD |
NASDAQ |
May 23, 16:00
1.75
0.00 (0.00%)
After-Hours: 17:19
I-MAB Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2022 | 69.78M |
June 30, 2022 | 21.50M |
December 31, 2021 | -113.07M |
Date | Value |
---|---|
June 30, 2021 | -54.75M |
June 30, 2020 | 27.45M |
June 30, 2019 | 25.43M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-113.07M
Minimum
Dec 2021
69.78M
Maximum
Dec 2022
-3.942M
Average
23.46M
Median
Cash from Investing (TTM) Benchmarks
Summit Therapeutics Inc | 77.16M |
Verastem Inc | -12.66M |
CEL-SCI Corp | -0.2721M |
AIM ImmunoTech Inc | -0.912M |
IGC Pharma Inc | -0.236M |